Home » Topics » BioWorld Science

BioWorld Science
RSS

PNV-2 reduces metastases in animal model of triple-negative breast cancer

Nov. 30, 2021

Discovery of novel antifungal compounds with improved metabolic stability

Nov. 30, 2021

New transgenic hACE2-expressing mouse model shows efficacy of vaccine against brain COVID-19

Nov. 30, 2021

B-cell targeting controls chronic viral infections in mice

Nov. 30, 2021

New RIPK1 inhibitors presented by National Institute of Pharmaceutical R&D

Nov. 30, 2021

Eli Lilly and Company identifies CSF1R inhibitors

Nov. 30, 2021

Txinno Bioscience presents new ENPP1 inhibitors

Nov. 30, 2021

Dartmouth College discloses new GR antagonists

Nov. 30, 2021

Shanghai Longwood Biopharmaceuticals divulges PD-1/PD-L1 interaction inhibitors

Nov. 30, 2021

IBI-319, a novel CD137/PD-1 bispecific antibody with limited systemic toxicity

Nov. 30, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...